FI59400C - Foerfarande foer framstaellning av neuroleptiska n-(p-fluorbenzoylpropyl)-4-piperidylamider och deras syraadditionssalter - Google Patents
Foerfarande foer framstaellning av neuroleptiska n-(p-fluorbenzoylpropyl)-4-piperidylamider och deras syraadditionssalter Download PDFInfo
- Publication number
- FI59400C FI59400C FI751317A FI751317A FI59400C FI 59400 C FI59400 C FI 59400C FI 751317 A FI751317 A FI 751317A FI 751317 A FI751317 A FI 751317A FI 59400 C FI59400 C FI 59400C
- Authority
- FI
- Finland
- Prior art keywords
- acid
- neuroleptic
- formula
- piperidylamider
- fluorbenzoylpropyl
- Prior art date
Links
- 239000003176 neuroleptic agent Substances 0.000 title claims description 6
- 230000000701 neuroleptic effect Effects 0.000 title claims description 6
- 238000005057 refrigeration Methods 0.000 title 1
- 239000002253 acid Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 3
- DODZXZATBLWUGA-UHFFFAOYSA-N 1-(4-fluorophenyl)-4-(piperidin-4-ylamino)butan-1-one Chemical class C1=CC(F)=CC=C1C(=O)CCCNC1CCNCC1 DODZXZATBLWUGA-UHFFFAOYSA-N 0.000 claims description 2
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 claims description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 2
- 229940071870 hydroiodic acid Drugs 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 14
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 8
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- -1 p-fluorobenzoylpropyl Chemical group 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229940025084 amphetamine Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 230000003354 anti-apomorphinic effect Effects 0.000 description 2
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 description 2
- 229960004046 apomorphine Drugs 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 229940125723 sedative agent Drugs 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QHDXPJMOWRLLRV-UHFFFAOYSA-N 1-(4-fluorophenyl)butan-1-one Chemical compound CCCC(=O)C1=CC=C(F)C=C1 QHDXPJMOWRLLRV-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000003291 dopaminomimetic effect Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 229960003878 haloperidol Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- XRKQMIFKHDXFNQ-UHFFFAOYSA-N n-cyclohexyl-n-ethylcyclohexanamine Chemical compound C1CCCCC1N(CC)C1CCCCC1 XRKQMIFKHDXFNQ-UHFFFAOYSA-N 0.000 description 1
- PWMUODAZHNQADN-UHFFFAOYSA-N n-piperidin-4-ylacetamide;hydrochloride Chemical compound Cl.CC(=O)NC1CCNCC1 PWMUODAZHNQADN-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000012346 open field test Methods 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2423897 | 1974-05-16 | ||
| DE2423897A DE2423897C3 (de) | 1974-05-16 | 1974-05-16 | N-(p-FluorbenzoyIpropyl)-4piperidylamide, Verfahren zu ihrer Herstellung und pharmazeutische Präparate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI751317A7 FI751317A7 (enrdf_load_stackoverflow) | 1975-11-17 |
| FI59400B FI59400B (fi) | 1981-04-30 |
| FI59400C true FI59400C (fi) | 1981-08-10 |
Family
ID=5915760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI751317A FI59400C (fi) | 1974-05-16 | 1975-05-05 | Foerfarande foer framstaellning av neuroleptiska n-(p-fluorbenzoylpropyl)-4-piperidylamider och deras syraadditionssalter |
Country Status (13)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4962115A (en) * | 1981-10-01 | 1990-10-09 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
| DE19952146A1 (de) * | 1999-10-29 | 2001-06-07 | Boehringer Ingelheim Pharma | Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
-
1974
- 1974-05-16 DE DE2423897A patent/DE2423897C3/de not_active Expired
-
1975
- 1975-04-23 AT AT310275A patent/AT342591B/de not_active IP Right Cessation
- 1975-04-28 ES ES437080A patent/ES437080A1/es not_active Expired
- 1975-05-05 FI FI751317A patent/FI59400C/fi not_active IP Right Cessation
- 1975-05-13 CH CH612075A patent/CH613445A5/xx not_active IP Right Cessation
- 1975-05-15 NO NO751724A patent/NO144671C/no unknown
- 1975-05-15 SE SE7505587A patent/SE416129B/xx unknown
- 1975-05-15 GB GB20708/75A patent/GB1500973A/en not_active Expired
- 1975-05-15 NL NL7505710A patent/NL7505710A/xx not_active Application Discontinuation
- 1975-05-15 BE BE156408A patent/BE829140A/xx not_active IP Right Cessation
- 1975-05-15 JP JP50057905A patent/JPS50160281A/ja active Pending
- 1975-05-15 DK DK213675A patent/DK213675A/da unknown
- 1975-05-16 FR FR7515385A patent/FR2270877B1/fr not_active Expired
- 1975-10-30 ES ES441383A patent/ES441383A1/es not_active Expired
-
1977
- 1977-01-07 AT AT4077A patent/AT342594B/de not_active IP Right Cessation
-
1979
- 1979-04-19 CH CH369979A patent/CH614704A5/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI751317A7 (enrdf_load_stackoverflow) | 1975-11-17 |
| FR2270877B1 (enrdf_load_stackoverflow) | 1978-10-06 |
| NO144671C (no) | 1981-10-14 |
| CH614704A5 (en) | 1979-12-14 |
| NL7505710A (nl) | 1975-11-18 |
| DK213675A (da) | 1975-11-17 |
| SE7505587L (sv) | 1975-11-17 |
| DE2423897B2 (de) | 1978-12-21 |
| SE416129B (sv) | 1980-12-01 |
| DE2423897C3 (de) | 1979-09-06 |
| ATA4077A (de) | 1977-08-15 |
| AT342594B (de) | 1978-04-10 |
| GB1500973A (en) | 1978-02-15 |
| BE829140A (fr) | 1975-11-17 |
| AT342591B (de) | 1978-04-10 |
| ES441383A1 (es) | 1977-04-01 |
| AU8119575A (en) | 1976-11-18 |
| JPS50160281A (enrdf_load_stackoverflow) | 1975-12-25 |
| ATA310275A (de) | 1977-08-15 |
| ES437080A1 (es) | 1977-02-01 |
| DE2423897A1 (de) | 1975-11-27 |
| FR2270877A1 (enrdf_load_stackoverflow) | 1975-12-12 |
| CH613445A5 (en) | 1979-09-28 |
| NO144671B (no) | 1981-07-06 |
| FI59400B (fi) | 1981-04-30 |
| NO751724L (enrdf_load_stackoverflow) | 1975-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6259103B2 (enrdf_load_stackoverflow) | ||
| CA1116611A (en) | Imidazole derivatives exhibiting anticonvulsant activity | |
| US4069223A (en) | 4-Aminomethyl-1-(3,3,3-triarylpropyl)-4-arylpiperidine and derivatives thereof | |
| FI80019C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara n-(piperidinyl-alkyl)karboxamider. | |
| US4207343A (en) | 1-Phenyl-3-(substituted phenoxy)propylamines | |
| Lunsford et al. | 4-(β-substituted ethyl)-3, 3-diphenyl-2-pyrrolidinones. A new series of CNS Stimulants1 | |
| FI59400C (fi) | Foerfarande foer framstaellning av neuroleptiska n-(p-fluorbenzoylpropyl)-4-piperidylamider och deras syraadditionssalter | |
| FI74950B (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva 2-/4-(difenylmetylen)-1-piperidinyl-aettiksyror. | |
| US4436746A (en) | Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles | |
| US3686187A (en) | 4-anilino-1-(4-p-fluorophenyl-1-butyl) piperidine compounds | |
| BG60556B1 (bg) | Амиди на циклометилен-1,2-дикарбоксилни киселинис терапевтична активност,методи за получаването им и фармацевтични състави, които ги съдържат | |
| US4057560A (en) | 1,2,2A,3,4,5 Hexahydrobenz[c,d]indol-1-yl-2-guanidines | |
| AU592985B2 (en) | New derivatives of 4-phenylpropyl indole and their salts, their preparation process, their use as medicaments and the pharmaceutical compositions containing them | |
| FR2618436A1 (fr) | Derives de piperidine, leur preparation et leur application en therapeutique | |
| Sato et al. | Psychotropic agents. 3. 4-(4-Substituted piperidinyl)-1-(4-fluorophenyl)-1-butanones with potent neuroleptic activity | |
| FI78682B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara oximetrar. | |
| KR900004694B1 (ko) | 신규 α-아릴-α-피리딜 알카노인산 유도체의 제조방법 | |
| FI59407B (fi) | Foerfarande foer framstaellning av neuroleptiska 1-/n-(p-fluorbenzoylpropyl)-4-piperidyl/-imidazolidinon(2)-derivat och deras syraadditionssalter | |
| US4431664A (en) | Compound with antiulcerogenic activity, process for the preparation thereof and pharmaceutical composition therefrom | |
| US4987137A (en) | Certain 6,7,8,9-tetrahydropyrido[1,2-α]indoles and their use for the treatment of cerebrovascular disorders | |
| US4129658A (en) | 4-Styryl-hexahydro-4-indolinols | |
| US3375278A (en) | 1, 1-bis(biphenylyl)-2-methyl-3-tertiary aminopropanols and salts thereof | |
| US3778449A (en) | Indenopyran-and indenothiopyran alkylamines | |
| US3644343A (en) | Phenyl and substituted phenylsulfonylallyl amines and substituted amines | |
| US4214095A (en) | Chlorobenzyl phenoxy alkoxylates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: C.H. BOEHRINGER SOHN |